Literature DB >> 14748872

Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from India.

Anil Bhansali1, Rakesh Kochhar, Yogesh K Chawla, Somashekara Reddy, Radharaman Jiban Dash.   

Abstract

BACKGROUND: There are conflicting data on the prevalence of colorectal adenomas in patients with acromegaly. It has been suggested that the risk of colorectal adenomas may be dependent on the geographic and ethnic origin of the patients. MATERIALS: Sixty consecutive patients with active acromegaly due to somatotropinoma underwent colonoscopy prior to definitive surgery. They included 35 men and 25 women with a mean (+/- SD) age of 37.4 +/- 13.2 years and a lag time between symptomatology and diagnosis of acromegaly of 64.6 +/- 58.0 months. The control group included 160 patients (88 men, 72 women; mean age, 38.2 +/- 14.0 years) with a diagnosis of irritable bowel syndrome who were also subjected to colonoscopy. None of these patients had previous or family history of colonic neoplasm, bleeding or colonic surgery.
RESULTS: Colonoscopic examination was complete to the cecum in 52 patients (88%), and to the splenic flexure in the remaining 12%. In the control group, it was complete to the cecum in 144 patients (90%). Four of the acromegalic patients (6.7%) and five in the control group (3.1%; P=0.24) had hyperplastic polyps. No patient in either of the groups had adenomatous polyps or colonic adenocarcinoma. The group of acromegalic patients with and without polyps did not differ significantly in age, duration of disease, growth hormone levels or glycemic status. The number of skin tags, however, was significantly higher (P=0.04) in the polyp group as compared to those without polyps.
CONCLUSION: The present study has failed to demonstrate the high prevalence rate of colonic neoplasia in patients with acromegaly as compared to reports from the Western world. Copyright 2004 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Year:  2004        PMID: 14748872     DOI: 10.1111/j.1440-1746.2003.03282.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Predictors of colonic pathologies in active acromegaly: single tertiary center experience.

Authors:  Raim Iliaz; Sema Ciftci Dogansen; Seher Tanrikulu; Gulsah Yenidunya Yalin; Bilger Cavus; Mine Gulluoglu; Filiz Akyuz; Sema Yarman
Journal:  Wien Klin Wochenschr       Date:  2018-07-30       Impact factor: 1.704

2.  Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?

Authors:  Pinaki Dutta; Anil Bhansali; Kim Vaiphei; Usha Dutta; P Ravi Kumar; Shariq Masoodi; Kanchan Kumar Mukherjee; Alka Varma; R Kochhar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

3.  Guidelines versus real life practice: the case of colonoscopy in acromegaly.

Authors:  M Parolin; F Dassie; L Russo; S Mazzocut; M Ferrata; E De Carlo; R Mioni; F Fallo; R Vettor; C Martini; P Maffei
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

4.  Colorectal neoplasm and acromegaly.

Authors:  Anil Bhansali; Pinaki Dutta; Mohammad Hayat Bhat; S K Sinha; R Kochar; K Vaiphi
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Authors:  Theodoros Rokkas; Dimitrios Pistiolas; Panos Sechopoulos; Georgios Margantinis; Georgios Koukoulis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 6.  Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Authors:  Kevin C J Yuen; Anthony P Heaney; Vera Popovic
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

7.  Prevalence of colonic polyp and its predictors in patients with acromegaly.

Authors:  Purnima Agarwal; Praveer Rai; Manoj Jain; Shambhavi Mishra; Uttam Singh; Sushil Kumar Gupta
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.